Alendronate

Overview

4.6 out of 5 (128 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Jan 2021

Last Review Date

12 Nov 2023

Expiration Date

31 Dec 2023

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Alendronate is approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis, steroid-induced osteoporosis, and male osteoporosis, as well as for the management of Paget disease of bone. Alendronate belongs to the class of bisphosphonate medications, which aids in the prevention of bone resorption and the promotion of bone density, making it a valuable treatment for osteoporosis and various other bone-related conditions. By binding to hydroxyapatite crystals within bone, alendronate downregulates osteoclast-mediated bone reabsorption, thereby leading to a reduction in bone matrix breakdown. Both of these mechanisms collectively contribute to regulating the reabsorption and turnover of minerals. This activity provides a comprehensive review of alendronate, including its indications, mechanism of action, specific patient populations, potential adverse effects, and the significance of monitoring during its administration. This activity also highlights the essential collaborative approach among interprofessional healthcare professionals for the effective treatment and prevention of osteoporosis.


Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the appropriate patient populations and conditions for which alendronate is indicated, including postmenopausal osteoporosis, steroid-induced osteoporosis, male osteoporosis, and Paget disease of bone.

  • Screen patients for contraindications and risk factors affecting alendronate therapy, such as esophageal abnormalities, delayed esophageal emptying, and hypocalcemia.

  • Apply knowledge of alendronate's mechanism of action to tailor treatment plans for specific patient needs, considering factors such as age, gender, and fracture risk.

  • Collaborate with other healthcare professionals to provide comprehensive education on alendronate therapy, potential adverse effects, and the importance of medication adherence for optimal patient outcomes.

Disclosures

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they or their immediate family may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CUSOM for resolution, to ensure fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

CUSOM will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for authors, editors, planners, peer reviewers, and/or relevant staff is provided with this activity.

Continuing Education Accreditation Information

 

 

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. CUSOM designates this enduring material for a maximum of 1.00 AOA Category 1 B Credits and will report CME credits commensurate with the extent of the physician's participation in the activity.

Cancellation Policy: Cancellations must be received in writing and a money back guarantee is provided if not completely satisfied.

  • StatPearls and CUSOM reserve the right to cancel any course due to unforeseen circumstances. StatPearls and CUSOM will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and CUSOM are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and CUSOM adheres to AOA Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and Campbell that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

This course is intended for osteopathic physicians who wish to earn AOA CME credit. Take this version of the course to ensure you receive appropriate credit.

 

 
 

Reviews

Lori W. on 6/18/2021

William B. on 8/6/2021

John Y. on 8/25/2021

Alana H. on 8/26/2021

Kelsey G. on 8/29/2021

Lisa R. on 10/21/2021

Patrick G. on 10/23/2021

Mary C. on 11/9/2021

Toni h. on 12/31/2021

Trenna R. on 12/31/2021

Georgiann B. on 1/9/2022

john e. on 2/19/2022

Russell R. on 3/10/2022

Michael M. on 3/21/2022

Stephanie B. on 3/31/2022

Michele D. on 5/1/2022

Paul H. on 5/8/2022

Amy R. on 5/6/2022

Jacinta U. on 5/9/2022

Christine D. on 5/11/2022

Shelia C. on 5/16/2022

Deanna K. on 5/22/2022

BURTON L. on 6/25/2022

Grace N. on 6/26/2022

Nancy F. on 6/27/2022

Dawn E. on 7/3/2022

Brittany T. on 8/1/2022

Kaitlin C. on 8/12/2022

Christina L. on 8/14/2022

Clifford A. on 8/24/2022

Alex N. on 8/30/2022

Shanon Z. on 9/4/2022

Rachel E. on 9/18/2022

Matthew S. on 10/22/2022

Charles W. on 11/19/2022

Amr K. on 12/1/2022

Holly J. on 12/14/2022

Kecia T. on 12/21/2022

Kelli M. on 12/22/2022

Rachael F. on 12/27/2022

Peter S. on 12/28/2022

Simranjit K. on 12/30/2022

Natalie p. on 1/2/2023

Brenna B. on 1/4/2023

syble c. on 1/14/2023

Florence Y. on 1/16/2023

Li s. on 1/23/2023

Stephanie C. on 1/26/2023

Lisa B. on 1/29/2023

Lea O. on 1/29/2023

brittany l. on 2/1/2023

Bonnie R. on 2/7/2023

Sharon B. on 2/12/2023

Mary Y. on 2/15/2023

Timothy A. on 2/17/2023

Rose F. on 3/1/2023

Stephanie B. on 3/10/2023

Przemyslaw L. on 3/11/2023

Brian B. on 3/13/2023

Rebecca S. on 3/29/2023

Shirley A. on 4/4/2023

Adel s. on 4/7/2023

Quarshiwaa A. on 4/10/2023

IRIS O. on 4/16/2023

Kinga V. on 4/16/2023

Lily L. on 4/30/2023

Amy L. on 5/7/2023

Linda on 5/12/2023

Michael K. on 6/9/2023

Christy S. on 6/29/2023

Natalie M. on 7/3/2023

BARBARA L. on 8/5/2023

Mergene T. on 8/5/2023

Whittney H. on 8/7/2023

Allynda H. on 8/29/2023

Katherine E. on 9/1/2023

Blessing O. on 9/5/2023

Michelle G. on 9/8/2023

Ryan H. on 9/16/2023

Elizabeth S. on 9/22/2023

Alannah C. on 9/26/2023

Jarrod G. on 9/28/2023

Stephen W. on 10/5/2023

Celynne A. on 10/15/2023

Jami P. on 10/19/2023

Vu H. on 10/19/2023

Kristopher H. on 10/24/2023

Lisa F. on 10/28/2023

Kody S. on 10/31/2023

Ashok V. on 11/6/2023

William S. on 11/12/2023

Shalamar S. on 11/12/2023

Ashley S. on 11/26/2023

Sahar E. on 11/26/2023

Nanette M. on 12/12/2023

Meril M. on 12/5/2023

Melissa B. on 12/13/2023

Larry M. on 12/22/2023

sandhya s. on 12/22/2023

Jocelyn R. on 12/22/2023

Michelle M. on 12/28/2023

Antonio D. on 12/30/2023

thank you

Opeyemi B. on 1/1/2024

Vu H. on 1/9/2024

Erika G. on 1/14/2024

osei b. on 1/15/2024

Rebecca C. on 1/19/2024

Karen B. on 1/20/2024

Natasha N. on 1/28/2024

Elizabeth A. on 2/1/2024

Lois C. on 2/19/2024

Ameena a. on 2/21/2024

Nicole T. on 2/23/2024

Benjamin S. on 2/28/2024

ISLAM A. on 2/28/2024

Genevieve M. on 3/2/2024

Shu-Yu K. on 3/3/2024

Laura C. on 3/14/2024

Jessica P. on 3/14/2024

Christopher K. on 3/15/2024

Jacob H. on 3/19/2024

Robin H. on 3/21/2024

Theresa J. on 3/23/2024

Margaret M. on 3/28/2024

Laura l. on 3/30/2024

Amy D. on 4/5/2024

larry m. on 4/14/2024

Megan M. on 4/17/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$39 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user